Weight loss 2.0: What next for the companies at the forefront of fighting global obesity
Investor excitement surrounding weight-loss drugs has arguably been as great if not greater than that seen for everything AI (artificial intelligence) in the last two years.Market leaders Novo Nordisk (NOVO-B:CPH) and Eli Lilly...
01 August 2024